Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Membrane stabilizer: citicoline.

Richard M Zweifler1

  • 1Stroke Center, University of South Alabama, Mobile 36617, USA. rzweifle@usouthal.edu

Current Medical Research and Opinion
|October 9, 2002
PubMed
Summary

Citicoline may protect brain cells from stroke damage by stabilizing membranes. While some studies show benefits, recent US trials have been inconclusive, suggesting specific patient groups or combination therapies may be needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of Conversion Disorder Diagnosis via Telestroke Network Consultation: A Retrospective Cohort Study.

Ochsner journal·2025
Same author

Diagnosis of Incident Cancer After Cryptogenic Stroke: An Exploratory Analysis of the ARCADIA Randomized Trial.

Neurology·2024
Same author

Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial.

JAMA neurology·2024
Same author

Diagnostic accuracy of telestroke consultation: a Louisiana based tele-network experience.

Frontiers in neurology·2023
Same author

Neurological Impact of Coronavirus Disease of 2019: Practical Considerations for the Neuroscience Community.

World neurosurgery·2020
Same author

Initial Assessment and Triage of the Stroke Patient.

Progress in cardiovascular diseases·2017

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Ischaemic stroke triggers biochemical events leading to neuronal cell membrane injury.
  • Protecting neuronal membranes is a potential therapeutic strategy for stroke.
  • Citicoline (cytidine-5-diphosphocholine; CDP-choline) is investigated for neuroprotection.

Purpose of the Study:

  • To evaluate the efficacy of citicoline in treating central nervous system (CNS) ischaemic injury.
  • To explore citicoline's potential to stabilize cell membranes and reduce free radical generation post-stroke.

Main Methods:

  • Review of animal models of ischaemic stroke and hypoxia.
  • Analysis of randomized clinical trials on citicoline treatment for stroke, including US and non-US studies.

Main Results:

  • Animal models suggest beneficial effects of citicoline.
  • Clinical trials outside the US showed promising results.
  • Recent US trials investigating citicoline for middle cerebral artery (MCA) stroke did not support its use.

Conclusions:

  • Citicoline is a well-tolerated therapy with potential benefits in specific patient subgroups, which require further definition.
  • Efficacy may be observed when citicoline is used in combination with other neuroprotective agents with complementary mechanisms.

Related Experiment Videos